 | Up a level |
Srivastava, Simran and Kumar, Sahil and Mishra, Suman and Rajmani, Raju S and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh Prakash and Varadarajan, Raghavan (2026) Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate. ACS Infect. Dis., 12 (1). pp. 104-118.
Kumar, Sahil and Delipan, Rathina and Sharma, Chanchal and Jadoun, Jyoti and Kanjo, Kawkab and Singh, Randhir and Rajmani, Raju and Deshpande, Suprit and Pandey, Rajesh and Thakur, Krishan G and Bhattacharya, Jayanta and Sanders, Rogier W and van Gils, Marit J and Varadarajan, Raghavan and Ringe, Rajesh P (2025) Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2. Nat. Commun., 16 (1). p. 10130.
Srivastava, Simran and Kumar, Sahil and Mishra, Suman and Rajmani, Raju S and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh Prakash and Varadarajan, Raghavan (2025) Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate. ACS Infect. Dis., 12 (1). pp. 104-118.
Chakraborty, Debajyoti and Singh, Randhir and Rajmani, Raju S. and Kumar, Sahil and Ringe, Rajesh P. and Varadarajan, Raghavan (2025) Stabilizing Prefusion SARS-CoV-2 Spike by Destabilizing the Postfusion Conformation. Vaccines, 13 (3).
Khan, Mohammad Suhail and Jakob, Virginie and Singh, Randhir and Rajmani, Raju S and Kumar, Sahil and Lemonie , Celine and Kleanthous , Harry and Ringe, Rajesh P. and Dubois , Patrice M and Varadarajan, Raghavan (2023) Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics, 15 (12).
Kumar, Nirmal and Taily, Irshad Maajid and Singh, Charandeep and Kumar, Sahil and Rajmani, Raju S and Chakraborti, Debajyoti and Sharma, Anshul and Singh, Priyanka and Thakur, Krishan Gopal and Varadarajan, Raghavan and Ringe, Rajesh P. and Banerjee, Prabal and Banerjee, Indranil (2023) Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. Plos Pathogens , 19 (5).
Khaleeq , Sara and Sengupta, Nayanika and Kumar, Sahil and Patel, U R and Rajmani, Raju S and Reddy , Poorvi and Pandey , Suman and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh P. and Varadarajan, Raghavan (2023) Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern. Viruses, 15 (2).
Khatri, Bhavesh and Pramanick, Ishika and Malladi , Sameer Kumar and Rajmani, Raju S and Kumar, Sahil and Ghosh , Pritha and Sengupta, Nayanika and Rahisuddin, R and Kumar , Narender and Kumaran , S and Ringe, Rajesh P and Varadarajan, Raghavan and Dutta, Somnath and Chatterjee, Jayanta (2022) A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein. Nature Chemical Biology .
Agarwal, Sakshi and Sharma, Arun and Bouzeyen, Rania and Deep, Amar and Sharma, Harsh and Mangalaparthi, K Kiran and Datta, Keshava K and Kidwai, Saqib and Gowda, Harsha and Varadarajan, Raghavan and Sharma, Datta Ravi and Thakur, Krishan Gopal and Singh, Ramandeep (2020) VapBC22 toxin-antitoxin system from Mycobacterium tuberculosis is required for pathogenesis and modulation of host immune response. Science Advances, 6 (23). pp. 1-14.
